The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
Figure 2
Increased superoxide production in the diabetic vasculature is significantly reduced following treatment with PPAR agonists, gemfibrozil, and rosiglitazone in streptozotocin diabetic apolipoprotein E knockout mice [32, 33].
